`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`AMARIN PHARMA, INC., AMARIN
`PHARMACEUTICALS IRELAND
`LIMITED, MOCHIDA
`PHARMACEUTICAL CO., LTD.,
`
`
`
`Plaintiffs,
`
`
`
`v.
`
`HIKMA PHARMACEUTICALS USA
`INC., HIKMA PHARMACEUTICALS
`PLC, AND HEALTH NET, LLC,
`
`
`Defendants.
`
`
`
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`
`C.A. No. 20-1630-RGA
`
`HIKMA’S MOTION TO DISMISS FIRST AMENDED COMPLAINT FOR
`FAILURE TO STATE A CLAIM UNDER FED. R. CIV. P. 12(B)(6)
`
`Defendants Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals Plc.’s
`
`(collectively “Hikma”) move the Court to dismiss Counts I-III in Plaintiffs’ First Amended
`
`Complaint (D.I. 17) for failure to state a claim under Fed. R. Civ. P. 12(b)(6). Support for
`
`Hikma’s Motion is set forth in the Opening Brief that accompanies this Motion.
`
`HEYMAN ENERIO
`GATTUSO & HIRZEL LLP
`
`/s/ Dominick T. Gattuso
`Dominick T. Gattuso (#3630)
`300 Delaware Avenue, Suite 200
`Wilmington, DE 19801
`(302) 472-7300
`dgattuso@hegh.law
`
`Attorneys for Defendants Hikma Pharmaceuticals
`USA Inc. and Hikma Pharmaceuticals PLC
`
`OF COUNSEL:
`
`Charles B. Klein
`Claire A. Fundakowski
`WINSTON & STRAWN LLP
`1901 L Street, N.W.
`Washington, DC 20036
`(202) 282-5000
`
`Hikma Pharmaceuticals
`
`IPR2022-00215
`
`Ex. 1037, p. 1 of 2
`
`
`
`Case 1:20-cv-01630-RGA-JLH Document 19 Filed 01/27/21 Page 2 of 2 PageID #: 804
`
`
`Eimeric Reig-Plessis
`WINSTON & STRAWN LLP
`101 California Street
`San Francisco, CA 94111
`(415) 591-6808
`
`Alison Heydorn
`WINSTON & STRAWN LLP
`35 W. Wacker Drive
`Chicago, Illinois 60601
`(312) 558-5600
`
`Dated: January 27, 2021
`
`
`
`2
`
`Hikma Pharmaceuticals
`
`IPR2022-00215
`
`Ex. 1037, p. 2 of 2
`
`